Document is current
Any future updates will be listed below
-
Authors
Saternos, Hannah C.
Forero, Kathleen V.
Meqdad, Mahmood A.
Buqaileh, Raghad
Sunderman, Clare L.
Gallagher, Gillian
Messer, William S. Jr.
Mohieldin, Ashraf M.
Mucci, Claudio A.
Kumariya, Sanjana
Osman, Islam A.
Burkett, James P.
AbouAlaiwi, Wissam A.
-
Funding
Funding for this research was provided by:
NIH (R15HL140523, 3R15HL140523-01S1, 3R15HL140523-01S2, 3R15HL140523-01S3)
Alzheimer’s Association (AARGD-NTF-22-972749,)
NIA (1R03AG080418-01)
American Heart Association (19PRE34430055)
American Foundation of Pharmaceutical Education (Gateway to Research Award)
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 16 January 2025
First Online: 30 January 2025
Competing interests
: The authors declare no competing financial interests. Dr. W.S.M. is the founder and president of Psyneurgy Pharmaceuticals LLC.
